Judit Laszy

672 total citations
18 papers, 528 citations indexed

About

Judit Laszy is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Judit Laszy has authored 18 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cellular and Molecular Neuroscience, 6 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Judit Laszy's work include Neuroscience and Neuropharmacology Research (6 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Receptor Mechanisms and Signaling (4 papers). Judit Laszy is often cited by papers focused on Neuroscience and Neuropharmacology Research (6 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Receptor Mechanisms and Signaling (4 papers). Judit Laszy collaborates with scholars based in Hungary, Sweden and Germany. Judit Laszy's co-authors include István Gyertyán, I. Laszlovszky, Katalin Sághy, Béla Kiss, Zsolt Szombathelyi, Margit Kapás, György Domány, Károly Tihanyi, Tamás Szabados and G Szabó and has published in prestigious journals such as Brain Research, Journal of Medicinal Chemistry and Journal of Cerebral Blood Flow & Metabolism.

In The Last Decade

Judit Laszy

18 papers receiving 515 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Judit Laszy Hungary 10 275 184 179 75 74 18 528
Katalin Sághy Hungary 14 317 1.2× 221 1.2× 203 1.1× 99 1.3× 58 0.8× 22 577
Lisa L. Kerman United States 6 330 1.2× 202 1.1× 144 0.8× 60 0.8× 88 1.2× 7 512
Arlene Stark United States 10 205 0.7× 155 0.8× 140 0.8× 47 0.6× 45 0.6× 11 393
Zsolt Némethy Hungary 10 265 1.0× 263 1.4× 229 1.3× 41 0.5× 32 0.4× 20 638
Mark J. Benvenga United States 16 319 1.2× 194 1.1× 67 0.4× 62 0.8× 116 1.6× 28 552
M.B. Assié France 8 281 1.0× 170 0.9× 103 0.6× 42 0.6× 35 0.5× 16 452
Peter Heusler France 13 316 1.1× 273 1.5× 89 0.5× 33 0.4× 49 0.7× 23 522
S.M. Sorensen United States 10 485 1.8× 258 1.4× 117 0.7× 99 1.3× 114 1.5× 15 676
A. Oblin France 8 260 0.9× 197 1.1× 219 1.2× 27 0.4× 97 1.3× 18 592
Hilary Donovan United States 6 298 1.1× 196 1.1× 92 0.5× 36 0.5× 59 0.8× 8 422

Countries citing papers authored by Judit Laszy

Since Specialization
Citations

This map shows the geographic impact of Judit Laszy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judit Laszy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judit Laszy more than expected).

Fields of papers citing papers by Judit Laszy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judit Laszy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judit Laszy. The network helps show where Judit Laszy may publish in the future.

Co-authorship network of co-authors of Judit Laszy

This figure shows the co-authorship network connecting the top 25 collaborators of Judit Laszy. A scholar is included among the top collaborators of Judit Laszy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judit Laszy. Judit Laszy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Hegedűs, Nikolett, Judit Laszy, István Gyertyán, et al.. (2015). Scopolamine provocation-based pharmacological MRI model for testing procognitive agents. Journal of Psychopharmacology. 29(4). 447–455. 7 indexed citations
2.
Kocsis, Pál, István Gyertyán, János Éles, et al.. (2014). Vascular Action as the Primary Mechanism of Cognitive Effects of Cholinergic, CNS-Acting Drugs, a Rat phMRI BOLD Study. Journal of Cerebral Blood Flow & Metabolism. 34(6). 995–1000. 11 indexed citations
3.
Veszelka, Szilvia, Judit Laszy, László Németh, et al.. (2013). Efflux transport of serum amyloid P component at the blood-brain barrier. European Journal of Microbiology and Immunology. 3(4). 281–289. 5 indexed citations
4.
Ágai-Csongor, Éva, György Domány, János Galambos, et al.. (2012). Discovery of cariprazine (RGH-188): A novel antipsychotic acting on dopamine D3/D2 receptors. Bioorganic & Medicinal Chemistry Letters. 22(10). 3437–3440. 74 indexed citations
5.
Gravius, Andreas, Judit Laszy, M. Pietraszek, et al.. (2011). Effects of 5-HT6 antagonists, Ro-4368554 and SB-258585, in tests used for the detection of cognitive enhancement and antipsychotic-like activity. Behavioural Pharmacology. 22(2). 122–135. 36 indexed citations
6.
Gyertyán, István, Béla Kiss, Katalin Sághy, et al.. (2011). Cariprazine (RGH-188), a potent D3/D2 dopamine receptor partial agonist, binds to dopamine D3 receptors in vivo and shows antipsychotic-like and procognitive effects in rodents. Neurochemistry International. 59(6). 925–935. 119 indexed citations
7.
Szabó, György, Balázs Varga, Mónika Vastag, et al.. (2009). Chemical and Biological Investigation of Cyclopropyl Containing Diaryl-pyrazole-3-carboxamides as Novel and Potent Cannabinoid Type 1 Receptor Antagonists. Journal of Medicinal Chemistry. 52(14). 4329–4337. 33 indexed citations
8.
Laszlovszky, I., Béla Kiss, István Gyertyán, et al.. (2008). RGH-188, a d3/d2 dopamine receptor antagonist/partial agonist atypical antipsychotic candidate. European Psychiatry. 23. S163–S163. 3 indexed citations
9.
Gyertyán, István, Katalin Sághy, Judit Laszy, et al.. (2008). Subnanomolar dopamine D3 receptor antagonism coupled to moderate D2 affinity results in favourable antipsychotic-like activity in rodent models: II. behavioural characterisation of RG-15. Naunyn-Schmiedeberg s Archives of Pharmacology. 378(5). 529–539. 50 indexed citations
10.
Szántay, Csaba, Anikó Gere, Béla Kiss, et al.. (2008). Synthesis and Evaluation of 2′-Hydroxyethyl trans-Apovincaminate Derivatives as Antioxidant and Cognitive Enhancer Agents. Journal of Medicinal Chemistry. 51(3). 479–486. 9 indexed citations
11.
Laszy, Judit, et al.. (2008). P.1.d.012 Comparison of donepezile, ispronicline, varenicline and vinpocetine in two types of learning paradigms in rodents. European Neuropsychopharmacology. 18. S255–S255. 1 indexed citations
12.
Sass, Miklós, et al.. (2007). Serum amyloid P component induces TUNEL-positive nuclei in rat brain after intrahippocampal administration. Brain Research. 1145. 221–226. 17 indexed citations
13.
Gyertyán, István, Béla Kiss, Katalin Sághy, et al.. (2006). P.3.d.006 Pharmacological profile of RGH-188, a novel dopamine D3/D2 receptor antagonist/partial agonist atypical antipsychotic. European Neuropsychopharmacology. 16. S432–S432. 4 indexed citations
14.
Laszy, Judit, I. Laszlovszky, & István Gyertyán. (2004). Dopamine D3 receptor antagonists improve the learning performance in memory-impaired rats. Psychopharmacology. 179(3). 567–575. 122 indexed citations
15.
Laszy, Judit, et al.. (1990). Hypoxia-Induced Sleep Disturbance in Rats. SLEEP. 13(3). 205–17. 20 indexed citations
16.
Szabo, Steven T., et al.. (1988). Effects of thyrotropin-releasing hormone and its analogue L-6-ketopiperidine-2-carbonyl-leucyl-L-prolin-amide on behaviour and electroencephalogram.. PubMed. 38(8). 1134–8. 10 indexed citations
17.
Bárdos, György & Judit Laszy. (1984). Learned aversion to mannitol in water-deprived rats. Physiology & Behavior. 33(4). 533–536. 2 indexed citations
18.
Bárdos, György, Judit Laszy, & György Ádám. (1981). Satiation evoked by distension of the small intestine in water deprived rats. Physiology & Behavior. 26(1). 7–12. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katalin Sághy Breakdown of academic impact, for papers by Lisa L. Kerman Breakdown of academic impact, for papers by Arlene Stark Breakdown of academic impact, for papers by Zsolt Némethy Breakdown of academic impact, for papers by Mark J. Benvenga Breakdown of academic impact, for papers by M.B. Assié Breakdown of academic impact, for papers by Peter Heusler Breakdown of academic impact, for papers by S.M. Sorensen Breakdown of academic impact, for papers by A. Oblin Breakdown of academic impact, for papers by Hilary Donovan
Rankless by CCL
2026